News Conference News ESC 2021 LOOP and STROKESTOP: Impact of AF Screening May Hinge on Arrhythmia Burden Todd Neale August 29, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News HRS 2021 J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’ Shelley Wood July 28, 2021
News Conference News ACC 2021 RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients Todd Neale May 17, 2021
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News ACC 2021 Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III Todd Neale May 15, 2021
News Conference News EHRA 2021 EHRA Updates Its Popular ‘Practical’ NOAC Guide Todd Neale April 29, 2021
News Conference News EHRA 2021 No Clear Explanation for Benefits of Early Rhythm Control in EAST-AFNET4 Todd Neale April 27, 2021
News Conference News EHRA 2021 STROKESTOP: Small Clinical Benefit Seen With Systematic AF Screening Todd Neale April 26, 2021
News Conference News EHRA 2021 RACE 3: Effects Wane for Targeted Therapy in Early AF, HF Todd Neale April 26, 2021
News Daily News VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear Shelley Wood March 17, 2021
News Conference News A-fib Screening Yields Promising Results, But Uncertainty Remains: mSToPS and VITAL-AF Todd Neale November 19, 2020
News Conference News AHA 2020 EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib Shelley Wood November 16, 2020
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News AHA 2020 Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm Todd Neale November 13, 2020